drugset / Trial / NCT06066918

Prophylactic Pregabalin Treatment Following Spinal Cord Injury

NCT06066918

Recruiting 50 enrolled Loewenstein Hospital
Non-randomizedParallel-groupOpen-labelPrevention

Summary

Patients arriving to rehabilitation up to 3 months following SCI will be given (study group) or not (control group) Lyrica (75X2). They will be followed for central pain development.

Timeline

Start
2021-07-13
Primary completion
2026-02-05
Completion
2026-02-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 75 mg

Indications